These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8158395)

  • 1. Regression of cardiac hypertrophy and night-time blood pressure reduction.
    Muiesan ML; Rizzoni D; Zulli R; Calebich S; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S300-1. PubMed ID: 8158395
    [No Abstract]   [Full Text] [Related]  

  • 2. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute blood pressure reduction in the presence of hypertensive cardiac hypertrophy: any interference with coronary circulation?
    Guazzi MD; Alimento M; Guazzi M; Maltagliati A; Pepi M
    Scand J Clin Lab Invest Suppl; 1989; 196():53-61. PubMed ID: 2530622
    [No Abstract]   [Full Text] [Related]  

  • 4. [Circadian changes in blood pressure and therapeutic consequences].
    Schrader J; Scheler F
    Internist (Berl); 1990 Oct; 31(10):662-8. PubMed ID: 2283211
    [No Abstract]   [Full Text] [Related]  

  • 5. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should reducing nocturnal blood pressure be a therapeutic target in CKD? The time is ripe for a clinical outcomes trial.
    Rahman M; Appel LJ
    Am J Kidney Dis; 2007 Dec; 50(6):901-3. PubMed ID: 18037089
    [No Abstract]   [Full Text] [Related]  

  • 7. Circadian blood pressure pattern in patients with treated hypertension and left ventricular hypertrophy.
    Klein W; Zweiker R; Eber B; Dusleag J; Brussee H; Rotman B
    Angiology; 1991 May; 42(5):379-86. PubMed ID: 1827968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronobiologic assessment of antihypertensive therapy.
    Tamura K; Kohno I; Tsuruta I; Ijiri H; Nakamura T
    Ann Ist Super Sanita; 1993; 29(4):693-704. PubMed ID: 7985930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of hypertensive hypertrophy.
    Motz W; Strauer BE
    Scand J Clin Lab Invest Suppl; 1989; 196():62-71. PubMed ID: 2530623
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of antihypertensive drugs on cardiac hypertrophy].
    Hayashi D
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():241-4. PubMed ID: 11028332
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diurnal blood-pressure profile under Polypress therapy].
    Kirchhoff HW
    MMW Munch Med Wochenschr; 1982 Jul; 124(29-30):679-81. PubMed ID: 6126809
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exaggerated morning surge in blood pressure in hypertension.
    Kario K; Ishikawa J
    Am J Hypertens; 2006 Oct; 19(10):1018. PubMed ID: 17027820
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
    J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New approaches in choosing the therapy of patients with hypertension].
    Ol'binskaia LI; Stiazhkin VIu; Iamshchikov SN
    Ter Arkh; 1989; 61(9):24-9. PubMed ID: 2531936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Morning blood pressure rise].
    Roca-Cusach A
    Nefrologia; 2002; 22 Suppl 3():39-46. PubMed ID: 12014301
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiac hypertrophy in hypertension].
    Yamasaki H; Kaku T; Ueda K
    Nihon Rinsho; 1992 May; 50 Suppl():400-5. PubMed ID: 1387425
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recent trend in the research of hypertension in Japan. Problems on the long-term treatment of hypertension--withdrawal of antihypertensive drugs and regression of cardiac hypertrophy].
    Imataka K; Fujii J
    Nihon Naika Gakkai Zasshi; 1988 Dec; 77(12):1816-9. PubMed ID: 2977984
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatability of refractory or resistant hypertension by personalized antihypertensive chronotherapy based on ambulatory monitoring of the arterial pressure].
    Cugini P
    Recenti Prog Med; 1996 Feb; 87(2):51-7. PubMed ID: 8725080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.